These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 9223476)

  • 1. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.
    Aiken C
    J Virol; 1997 Aug; 71(8):5871-7. PubMed ID: 9223476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.
    Akari H; Uchiyama T; Fukumori T; Iida S; Koyama AH; Adachi A
    J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity.
    Aiken C
    Virology; 1998 Aug; 248(1):139-47. PubMed ID: 9705263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems.
    Luo T; Douglas JL; Livingston RL; Garcia JV
    Virology; 1998 Feb; 241(2):224-33. PubMed ID: 9499797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
    Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
    J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.
    Billich A; Hammerschmid F; Peichl P; Wenger R; Zenke G; Quesniaux V; Rosenwirth B
    J Virol; 1995 Apr; 69(4):2451-61. PubMed ID: 7884893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.
    Braaten D; Franke EK; Luban J
    J Virol; 1996 Jun; 70(6):3551-60. PubMed ID: 8648689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.
    Pizzato M; Popova E; Göttlinger HG
    J Virol; 2008 Nov; 82(21):10811-9. PubMed ID: 18715908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nef enhances HIV-1 infectivity via association with the virus assembly complex.
    Qi M; Aiken C
    Virology; 2008 Apr; 373(2):287-97. PubMed ID: 18191978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein.
    Sandrin V; Cosset FL
    J Biol Chem; 2006 Jan; 281(1):528-42. PubMed ID: 16195228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective restriction of Nef-defective human immunodeficiency virus type 1 by a proteasome-dependent mechanism.
    Qi M; Aiken C
    J Virol; 2007 Feb; 81(3):1534-6. PubMed ID: 17108041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.
    Khan M; Jin L; Huang MB; Miles L; Bond VC; Powell MD
    J Virol; 2004 Feb; 78(4):1843-50. PubMed ID: 14747548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.
    Braaten D; Ansari H; Luban J
    J Virol; 1997 Mar; 71(3):2107-13. PubMed ID: 9032343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
    Yu D; Wang W; Yoder A; Spear M; Wu Y
    PLoS Pathog; 2009 Oct; 5(10):e1000633. PubMed ID: 19851458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
    Usami Y; Popov S; Göttlinger HG
    J Virol; 2014 Mar; 88(6):3443-54. PubMed ID: 24403584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env.
    Lenardo MJ; Angleman SB; Bounkeua V; Dimas J; Duvall MG; Graubard MB; Hornung F; Selkirk MC; Speirs CK; Trageser C; Orenstein JO; Bolton DL
    J Virol; 2002 May; 76(10):5082-93. PubMed ID: 11967324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
    Schaeffer E; Geleziunas R; Greene WC
    J Virol; 2001 Mar; 75(6):2993-3000. PubMed ID: 11222724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
    Bartz SR; Vodicka MA
    Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.